How Mtb 3B-hydroxysteroid dehydrogenase accesses host cholesterol
Project Number3R01AI178685-02S1
Former Number1R01AI178685-01A1
Contact PI/Project LeaderPHILIPS, JENNIFER A
Awardee OrganizationWASHINGTON UNIVERSITY
Description
Abstract Text
SUMMARY (for Supplement)
Mycobacterium tuberculosis (Mtb) causes one of the world's most deadly infections. How Mtb modulates the
host immune response in order to establish infection, persist in the face of adaptive immunity, and elicit tissue
pathology to transmit is not well understood. Mtb grows intracellularly in lipid-laden (foamy) macrophages and
extracellularly within cholesterol-rich caseum of liquified granulomas. Mtb does not make cholesterol, but Mtb
can degrade host cholesterol and use it as a carbon source. The host modifies cholesterol by enzymatically
oxidizing it to a variety of derivatives, called oxysterols, which modulate the immune response. We found that
two oxidized cholesterol metabolites, cholestenone and 3-oxocholestenoic acid, accumulate in Mtb-infected
mouse lung, rabbit granulomas, and human sputum. The Mtb enzyme, 3-hydroxysteroid dehydrogenase
(Hsd/Rv1106c), converts the hydroxy residue at the third carbon position of cholesterol to a keto moiety. The
hypothesis underlying our parent grant is that Mtb Hsd disrupts the repertoire of cholesterol metabolites,
including immune active oxysterols, by converting them from 3-hydroxy to 3-oxo-derivatives, thereby interfering
with the host immune response. We found that in vitro and during macrophage infections Hsd is essential for
converting cholesterol to its 3-oxo-derivative, cholestenone. However, how Hsd accesses host cholesterol is
unclear. The previous literature assumed that cholesterol had to be imported into Mtb through the Mce4
cholesterol importer in order to undergo this oxidation step, which was thought to be a required first step in
cholesterol degradation. However, our new preliminary data demonstrate that cholesterol does not have to be
imported into Mtb to be oxidized, suggesting that cholestenone is generated outside of the bacteria, where it can
impact host cell processes. How Hsd, which lacks a signal sequence, is being exported from Mtb and where it
accesses host cholesterol is unknown. In this NIH Research Supplement to Promote Diversity in Health-Related
Research, we will determine whether Hsd is in extracellular vesicles (EVs), establish where Hsd localizes within
host cells, and examine the role of bacterial and host factors in cholesterol oxidation. These experiments support
the overall objectives of the parent grant, while following up on an exciting new finding. The supplement will
extend our work mechanistically and provide a high quality experimental plan to ensure Jalalah Muhammad's
career development and future success.
Public Health Relevance Statement
PROJECT NARRATIVE
Mycobacterium tuberculosis (Mtb)- the causative agent of tuberculosis (TB)- is able to establish infection in the
lungs, persist in humans for years, and kill more people than any other bacteria. The scientific goal of this
supplement is to determine how the Mtb enzyme, 3-hydroxysteroid dehydrogenase, accesses host
cholesterol to modify the host inflammatory response and promote disease pathogenesis. These findings could
lead to novel therapies and diagnostics for TB.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AchyroclineAcidsBacillusBacteriaCarbonCell PhysiologyCell membraneCellsCellular MembraneCholesterolDataDiseaseEnsureEnzymesEscherichia coliFutureGoalsGranulomaHealthHumanHydroxysteroid DehydrogenasesImmuneImmune responseIn VitroInfectionInflammatory ResponseIntegration Host FactorsLipidsLiteratureLungMacrophageMedicalMusMycobacterium tuberculosisOryctolagus cuniculusParentsPathogenesisPathologyPeptide Signal SequencesPersonal SatisfactionPersonsPositioning AttributeProductionProteinsProtocols documentationPublishingRecombinantsResearchResearch InstituteRoleSignal TransductionSourceSputumSupervisionTestingTissuesTrainingTuberculosisUnited States National Institutes of HealthWorkadaptive immunitycareer developmentexperimental studyextracellularextracellular vesiclesimmunoregulationinsightnovel diagnosticsnovel strategiesnovel therapeuticsoxidationparent grantpathogenpolyclonal antibodypublic health researchsuccesstransmission processtuberculosis diagnosticstuberculosis treatment
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
068552207
UEI
L6NFUM28LQM5
Project Start Date
13-February-2024
Project End Date
31-December-2028
Budget Start Date
14-January-2025
Budget End Date
31-December-2025
Project Funding Information for 2025
Total Funding
$67,754
Direct Costs
$43,572
Indirect Costs
$24,182
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Allergy and Infectious Diseases
$67,754
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3R01AI178685-02S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01AI178685-02S1
Patents
No Patents information available for 3R01AI178685-02S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01AI178685-02S1
Clinical Studies
No Clinical Studies information available for 3R01AI178685-02S1
News and More
Related News Releases
No news release information available for 3R01AI178685-02S1
History
No Historical information available for 3R01AI178685-02S1
Similar Projects
No Similar Projects information available for 3R01AI178685-02S1